NeuroGeneces, Inc. — SEC Form D Filing

NeuroGeneces, Inc. filed an SEC Form D on May 1, 2026, reporting $425K raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
May 1, 2026
Amount reported
$425K
Round stage
Seed
Industry
Health Technology
Website
https://neurogeneces.com/

What the company does

Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

There is a need for early detection of changes in brain function to enable timely interventions, particularly because slow-wave sleep plays a crucial role in memory consolidation.

Solution

NeuroGeneces offers a sleep headband that captures brain activity and uses AI algorithms to measure neurophysiological biomarkers, potentially enhancing memory consolidation through the synchronization of brain waves with sound.

Why now

There is a growing awareness of brain health and the importance of sleep for cognitive functions, making accessible at-home assessments timely and relevant.

Verdict

Investors opted in because of the urgent need for accessible brain health monitoring, not because of a proven market fit. They were implicitly betting on the convergence of increased consumer health awareness and innovative technology to create a unique solution. However, the limited upside lies in the product’s dependency on consumer adoption amidst the crowded wellness market and the risks associated with unvalidated claims.

Source: SEC EDGAR Form D filing